Results 171 to 180 of about 2,249,082 (267)

Therapeutic use of rTMS [PDF]

Nature Reviews Neuroscience, 2007
openaire   +2 more sources

Therapeutic Use of <i>Parerythrobacter</i> sp. M20A3S10, a Marine Bacterium, Targeting Influenza Viruses and Flaviviruses. [PDF]

Animals (Basel)
Moon KS, Chung JY, Moon HJ, Lee G, Lee CD, Jung SB, Kim HJ, Park JG, Baek YB, Park SI.   +9 more
europepmc   +1 more source

Structural insights into an engineered feruloyl esterase with improved MHET degrading properties

FEBS Letters, EarlyView.
A feruloyl esterase was engineered to mimic key features of MHETase, enhancing the degradation of PET oligomers. Structural and computational analysis reveal how a point mutation stabilizes the active site and reshapes the binding cleft, expading substrate scope.
Panagiota Karampa, Konstantinos Makryniotis, Theofani‐Iosifina Sousani, Evangelos Topakas, Vangelis Daskalakis, Maria Dimarogona   +5 more
wiley   +1 more source

On the Therapeutic Use of Iodoform [PDF]

BMJ, 1878
openaire   +2 more sources

Case report: Therapeutic use of bortezomib in a patient with Schnitzler syndrome. [PDF]

Front Immunol
Bai H, Zhou D, Liu J, He J, Min Z, Fan W, Chen B, Xu Y.   +7 more
europepmc   +1 more source

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

FEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

Proteolytic dysfunction in bovine digital dermatitis caused by Treponema spp. and the therapeutic use of non-antimicrobial matrix metalloproteinase inhibitors. [PDF]

Commun Biol
Lahiri P, Young D, Penner R, Lesack K, Dias AP, Hannawayya R, De Buck J, Orsel K, Hollenberg MD, Johnson F, Golub L, Scaduto J, Dufour A, Cobo ER.   +13 more
europepmc   +1 more source

Valosin‐containing protein counteracts ATP‐driven dissolution of FUS condensates through its ATPase activity in vitro

FEBS Letters, EarlyView.
Biomolecular condensates formed by fused in sarcoma (FUS) are dissolved by high ATP concentrations yet persist in cells. Using a reconstituted system, we demonstrate that valosin‐containing protein (VCP), an AAA+ ATPase, counteracts ATP‐driven dissolution of FUS condensates through its D2 ATPase activity.
Hitomi Kimura, Shin‐ichi Tate, Kyota Yasuda   +2 more
wiley   +1 more source

Recent advances in therapeutic use of transforming growth factor-beta inhibitors in cancer and fibrosis. [PDF]

Front Oncol
Jing H, Gao Y, Jing L, Yang H, Liu S.
europepmc   +1 more source

Diversity and complexity in neural organoids

FEBS Letters, EarlyView.
Neural organoid research aims to expand genetic diversity on one side and increase tissue complexity on the other. Chimeroids integrate multiple donor genomes within single organoids. Self‐organising multi‐identity organoids, exogenous cell seeding, or enforced assembly of region‐specific organoids contribute to tissue complexity.
Ilaria Chiaradia, Madeline A. Lancaster
wiley   +1 more source